Biolase Inc [NASDAQ: BIOL] price plunged by -5.19 percent to reach at -$0.01. The company report on March 21, 2024 at 4:05 PM that Biolase Reports Full-Year 2023 Results; Expects Continued Revenue Growth In 2024. BIOLASE, Inc. (NASDAQ:BIOL), the globally recognized leader in dental laser
Biolase Inc [NASDAQ: BIOL] closed the trading session at $0.18. The company report on March 21, 2024 at 4:05 PM that Biolase Reports Full-Year 2023 Results; Expects Continued Revenue Growth In 2024. BIOLASE, Inc. (NASDAQ:BIOL), the globally recognized leader in dental laser technology, who previously
Biolase Inc [NASDAQ: BIOL] traded at a high on Wednesday, posting a 6.50 gain after which it closed the day’ session at $0.15. The company report on March 14, 2024 at 6:30 AM that BIOLASE to Report Fourth Quarter and Full Year 2023 Results on
Biolase Inc [NASDAQ: BIOL] traded at a high on Friday, posting a 14.13 gain after which it closed the day’ session at $0.16. The company report on February 22, 2024 at 6:30 AM that Biolase Launches State-of-the-Art All-Tissue Laser System To Accelerate Adoption of Lasers
Biolase Inc [NASDAQ: BIOL] loss -6.73% or -0.01 points to close at $0.14 with a heavy trading volume of 4040340 shares. The company report on February 22, 2024 at 6:30 AM that Biolase Launches State-of-the-Art All-Tissue Laser System To Accelerate Adoption of Lasers in Dentistry.
Biolase Inc [NASDAQ: BIOL] stock went on an upward path that rose over 1.22% on Tuesday, amounting to a one-week price decrease of less than -66.64%. The company report on February 20, 2024 at 6:30 AM that Biolase Announces First Quarter 2024 Webinar Series ‘Lets
Biolase Inc [NASDAQ: BIOL] price plunged by -63.18 percent to reach at -$0.28. The company report on February 13, 2024 at 9:15 AM that BIOLASE, Inc. Announces Pricing of $7.0 Million Public Offering. BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, today announced the
© 2024, Powered by Smart TechOne
